The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Inhaled Bronchodilators Reduce Dynamic Hyperinflation During Exercise in Patients With Chronic Obstructive Pulmonary Disease
Abstract
Dynamic hyperinflation (DH) is a major pathophysiologic consequence of airflow limitation during exercise in patients with chronic obstructive pulmonary disease (COPD) and an important contributing factor to breathlessness. In this study we aimed to examine the effect of inhaled beta agonist therapy on DH during exercise in these patients and the relationship between changes in DH and breathlessness. In 13 COPD patients (mean age 65.1 +/- 2.0, FEV1 1.20 +/- 0.17, FEV1/FVC 40 +/- 3) we measured pulmonary function tests, exercise breathlessness by Borg score, and exercise flow volume and pressure volume loops on two separate days. Prior to testing, patients randomly received inhaled placebo or albuterol on the first test day and the alternative medication on the second test day. From measurements of exercise inspiratory capacity (IC), we calculated the end-expiratory and end-inspiratory lung volumes (EELV, EILV). We used esophageal pressure recordings to measure peak inspiratory esophageal pressure (Pesins) during exercise and this was related to the maximal capacity for pressure generation taking into account lung volume and airflow changes (Pcapi). Bronchodilator caused significant increase in both FEV1 and FVC (+0.23 and +0.51, p<0.01). Comparisons of breathlessness, exercise volumes, and pressures were made at the highest equivalent work load. There was a significant reduction in the peak exercise EELV/TLC (80 +/- 0.02% to 76 +/- 0.02%, p<0.05) while the peak EILV/TLC decreased by 2% (97 +/- 1% to 95 +/- 1%, p<0.05). The peak Pesins/Pcapi decreased (0.79 +/- 0.10 to 0.57 +/- 0.05, p<0.05), and the Pcapi - Pesins increased (7.4 +/- 3 to 13.0 +/- 3 cm H2O, p<0.05). There was significant improvement in neuroventilatory coupling for volume change (Pesins/Pcapi/VT/TLC 5.45 +/- 0.5 to 3.25 +/- 1.0, p<0.05). There was a significant reduction in breathlessness as measured by Borg score (4.5 +/- 0.7 to 3.1 +/- 0.5, p<0.05) and there was a significant correlation between delta Borg and delta EILV/TLC (r=0.771, p<0.01) with a trend for Pesins/Pcapi/VT/TLC (r=0.544, p=0.067). There was also a significant correlation between delta EELV/TLC and delta Pesins/Pcapi/VT/TLC (r=0.772, p<0.01). The relationships between delta Borg, delta resting volumes, and flow rates were not significant. We conclude that in patients with COPD, inhaled bronchodilator reduces exercise DH and improves inspiratory pressure reserve and neuroventilatory coupling. Changes in DH and neuroventilatory coupling were the main determinants of reduced breathlessness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, interventions that deflate the lungs (ie, reduce EILV and EELV) and delay the onset of critical VT constraints consistently reduce dyspnea intensity in patients with COPD during exercise.45,46,55,56”
From Pathogenesis of hyperinflation in chronic obstructive pulmonary disease (2014) · cites this paper as [55]
In the citing paper
“Pharmacological interventions that reduce operating lung volumes and delay the onset of ventilatory limitation consistently reduce the intensity of dyspnea during exercise in patients with COPD.46,55,56”
From Pathogenesis of hyperinflation in chronic obstructive pulmonary disease (2014) · cites this paper as [55]
Citations
Cites
Psychophysical bases of perceived exertion
BORG, G. A. V. (1982) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-198205000-00012 · Cited by 16,580
Standardization of Spirometry — 1987 Update
Buist, A. S. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.5.1073 · Cited by 3,256
O'Donnell, D. E., & Webb, K. A. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.5.1351 · Cited by 543
The n-of-1 Randomized Controlled Trial: Clinical Usefulness
Guyatt, G., Keller, J. L., Jaeschke, R., Rosenbloom, D., Adachi, J. D., & Newhouse, M. T. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-4-293 · Cited by 320
Pulmonary mechanics during exercise in subjects with chronic airflow obstruction
Stubbing, D. G., Pengelly, L. D., Morse, J. L., & Jones, N. L. (1980) · Journal of Applied Physiology · doi:10.1152/jappl.1980.49.3.511 · Cited by 314
Potter, W. A., Ólafsson, S., & Hyatt, R. E. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106563 · Cited by 241
Murciano, D., Auclair, M.-H., Parienté, R., & Aubier, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906083202304 · Cited by 223
Chest wall mechanics during exercise in patients with severe chronic air-flow obstruction.
Dodd, D., Brancatisano, T. P., & Engel, L. A. (1984) · PubMed · doi:10.1164/arrd.1984.129.1.33 · Cited by 195
Effect of mild-to-moderate airflow limitation on exercise capacity
Babb, T. G., Viggiano, R. W., Hurley, B. F., Staats, B., & RODARTE, J. R. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.70.1.223 · Cited by 195
Dose response relation to oral theophylline in severe chronic obstructive airways disease.
Chrystyn, H., Mulley, B. A., & Peake, M. D. (1988) · BMJ · doi:10.1136/bmj.297.6662.1506 · Cited by 164
Cited by
Sorted by citations
Items 301–400 of 401
Prevention of air leaks after lung surgery.
Venuta, F., Rendina, E., Giacomo, T. D., & Coloni, G. (1999) · Chest · doi:10.1378/chest.115.6.1759-a · Cited by 4
Tidal Flow-Volume Analysis of Ventilation During Exercise
Levine, S. (1999) · CHEST Journal · doi:10.1378/chest.116.2.277 · Cited by 3
In favour of respiratory muscle training
McConnell, A. (2005) · Chronic Respiratory Disease · doi:10.1191/1479972305cd094xx · Cited by 2
Gautam, S., Antin, G., & Pujar, K. (2023) · Medical Research Archives · doi:10.18103/mra.v11i7.1.4032 · Cited by 2
Pleasants, R. A., Shaikh, A., Henderson, A. G., Bayer, V., & Drummond, M. (2024) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2023.0045 · Cited by 2
Alternative and Complementary Treatments in Respiratory Diseases in the Elderly
Cherniack, N. S. (2003) · Springer eBooks · doi:10.1007/978-3-662-05185-6_24 · Cited by 2
Inhalation and Incubation with Procaterol Increases Diaphragm Muscle Contractility in Mice
Shindoh, C., Sasaki, K., Shindoh, Y., & Tamura, G. (2007) · Allergology International · doi:10.2332/allergolint.o-06-463 · Cited by 2
Lee, J. E., Min, B. R., Park, J. S., Park, H. P., Jun, M. J., Won, K. S., & Choi, W. I. (2006) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2006.60.6.631 · Cited by 2
Inspiratory Capacity and Exercise Tolerance in Chronic Obstructive Pulmonary Disease
Milic‐Emili, J., & Tantucci, C. (2002) · Springer eBooks · doi:10.1007/978-88-470-2916-3_17 · Cited by 2
Tashkin, D. P. (2005) · Current Opinion in Internal Medicine · doi:10.1097/00132980-200506000-00015 · Cited by 2
Tidal Flow-Volume Loop Enveloping at Rest in Advanced COPD
Fröhlich, L. F., Balzan, F. M., Plachi, F., Gass, R., Mendes, N. B. S., da Silva, D. P., Sanches, P. R. S., Knorst, M. M., Neder, J. A., & Berton, D. C. (2019) · Respiratory Care · doi:10.4187/respcare.06787 · Cited by 2
Enfermedad pulmonar obstructiva crónica (II)
Fábregas, M. L. (2010) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(10)70184-0 · Cited by 2
Mode d'action des bronchodilatateurs dans la BPCO
Roche, N. (2004) · La Presse Médicale · doi:10.1016/s0755-4982(04)98498-9 · Cited by 1
Park, H., Park, S.-H., Lee, S. W., Seo, Y., Lee, J., Seo, C., Kwak, J., Jeon, Y., Lee, M.-Y., Chung, I.-S., et al. (2004) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2004.57.2.143 · Cited by 2
Tonnel, A., Tillie‐Leblond, I., Attali, V., Bavelele, Z., & Lagrange, O. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.07.009 · Cited by 1
Gilchrist, F., Kon, O. M., & Polkey, M. I. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7939-2_3 · Cited by 1
Management Guidelines for Chronic Obstructive Pulmonary Disease
Celli, B. R. (2010) · Humana Press eBooks · doi:10.1007/978-1-59745-357-8_5 · Cited by 1
Integrative Therapies for People with Chronic Obstructive Pulmonary Disease
Donesky, D. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-579-4_4 · Cited by 1
Özgür, E. S., Atış, S. Ö., & Kanık, A. (2008) · PubMed · Cited by 1
Static and Dynamic Hyperinflation in Chronic Obstructive Pulmonary Disease
Laveneziana, P., Webb, K. A., & O’Donnell, D. E. (2014) · Springer eBooks · doi:10.1007/978-88-470-5647-3_7 · Cited by 1
SINGLE DOSE OF TIOTROPIUM DOES NOT EFFECT HEART RATE VARIABILITY
Ünlü, M., Melek, M., Fidan, F., Kılıt, C., Tetik, L., & Kaya, D. (2006) · Electronic Journal of General Medicine · doi:10.29333/ejgm/82388 · Cited by 1
Breathing Techniques for Breathlessness
Booth, S., Burkin, J., Moffat, C., & Spathis, A. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4754-1_5 · Cited by 1
Breathing Easier: Respiratory Disease in the Older Adult
Mahmudi‐Azer, S. (2010) · Wiley eBooks · doi:10.1002/9781118281796.ch4 · Cited by 1
COPD: Clinical Presentation and Evaluation
Celli, B. R. (2007) · doi:10.1002/9780470755976.ch15 · Cited by 1
The Physiology of Breathlessness
Mahler, D. A. (2007) · Wiley eBooks · doi:10.1002/9780470755976.ch2 · Cited by 1
Broncodilatadores de acción corta: ¿qué lugar les reservamos?
Río, F., Prieto, M. R. R., & Fernández, A. (2005) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(05)70734-1 · Cited by 1
Akute Effekte von Bronchodilatatoren auf Lungenfunktion und Dyspnoe bei Patienten mit COPD
Taube, C., Jörres, R., & Magnussen, H. (2000) · Pneumologie · doi:10.1055/s-2000-3825 · Cited by 1
Physical training and testing in patients with chronic obstructive pulmonary disease
Arnardóttir, R. H. (2007) · The Clinical Respiratory Journal · doi:10.1111/j.1752-699x.2007.00011.x · Cited by 1
Medical management of chronic obstructive pulmonary disease.
Sciurba, F. (2003) · Chest Surgery Clinics of North America · doi:10.1016/s1052-3359(03)00099-1 · Cited by 1
Pereira, C. A. D. C. (2005) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132005000500003 · Cited by 1
Sciurba, F. C., Richter, K. R., Kesten, S., Maltais, F., Hamilton, A. L., Marciniuk, D. D., & Hernandez, P. (2007) · Cited by 1
Novel Concepts in the Pharmacotherapy of Chronic Obstructive Pulmonary Disease
Celli, B. R. (2008) · Advances in respiratory medicine · doi:10.5603/arm.27857 · Cited by 1
Mackay, A. J., & Wedzicha, J. A. (2013) · European Respiratory Society eBooks · doi:10.1183/9781849840415.005312 · Cited by 1
Jensen, D. (2008) · QSpace (Queen's University Library) · Cited by 1
Wouters, E. F. �. (2002) · Cited by 1
Mahler, D. A. (2003) · Lung biology in health and disease · doi:10.1201/9780203913406.ptc · Cited by 1
Evaluation of New Drugs for Asthma and COPD: Endpoints, Biomarkers and Clinical Trial Designs
Barnes, P. J., Erin, E. M., Hansel, T. T., Kharitonov, S. A., Tan, A. J., & Tennant, R. C. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-09264-4_12
Gigliotti, F., Coli, C., Bianchi, R., Romagnoli, P., Lanini, B., Binazzi, B., & Scano, G. (2003) · Revista Portuguesa de Pneumologia · doi:10.1016/s0873-2159(15)30695-4
Use of Optoelectronic Plethysmography in Pulmonary Rehabilitation and Thoracic Surgery
Bruni, G., Gigliotti, F., & Scano, G. (2013) · InTech eBooks · doi:10.5772/53039 · Cited by 1
What is an Acute Exacerbation of COPD?
Wedzicha, W. (2003) · doi:10.1002/9780470755198.ch15
Bronchopneumopathie chronique obstructive et activité physique
Coste, O., & Grillon, J.-L. (2009) · Elsevier eBooks · doi:10.1016/b978-2-294-70215-0.00011-9
Testing for exercise limitation in obstructive lung disease.
Newton, M., Webb, K., & O'Donnell, D. (1999) · Chest · doi:10.1378/chest.115.6.1755-a
Assessment of Disability: What Test, or Combination of Tests, Should be Used?
O’Donnell, D. E., & Fitzpatrick, M. (2003) · doi:10.1002/9780470755198.ch5
Baldi, B. G. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2012.tde-14012013-143812
Aspects of inflammation in chronic obstructive pulmonary disease : a clinical study
Löfdahl, M. (2006) · Figshare
CONSIDERACIONES NOVEDOSAS SOBRE LA ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA
Bruce, A. A., & Sed, J. R. (2007) · Revista Archivo Médico de Camagüey
STALIŠČE DO OBRAVNAVE AKUTNEGA POSLABŠANJA KRONIČNE OBSTRUKTIVNE PLJUČNE BOLEZNI (apKOPB)
Kristan, S. Š., Šifrer, F., Guček, N. K., Osolnik, K., Eržen, R., Fležar, M., Petek, D., ml., J. Š., Tomič, V., Mušič, E., et al. (2009) · DOAJ (DOAJ: Directory of Open Access Journals)
Teramoto, S., & Ouchi, Y. (1999) · Respiratory Medicine · doi:10.1016/s0954-6111(99)90014-8
Is adjuvant chemotherapy for non-small cell lung cancer here to stay?
Warke, T. J. (2005) · Thorax · doi:10.1136/thx.2005.la0167
Épreuves fonctionnelles respiratoires dans l’asthme réfractaire
Garcia, G., Pérez, T., & Didier, A. (2008) · La Presse Médicale · doi:10.1016/j.lpm.2007.10.005
Budesonide/formoterol may be used for adjustable maintenance dosing in asthma
Simcock, D. E. (2004) · Thorax · doi:10.1136/thx.2004.la0095
Diagnostic Imaging of Lung Cancer by MRI
Bredow, S., Esparza, D., Divine, K., & Kuethe, D. (2004) · Experimental Lung Research · doi:10.1080/01902140490481359 · Cited by 1
Hitos sobre el test cardiopulmonar de ejercicio
Rodrigo Soto, F., & S, I. C. (2008) · Revista chilena de enfermedades respiratorias · doi:10.4067/s0717-73482008000200005
Fazio, D. D. (2010) · Victoria University Research Repository (Victoria University)
Diurnal Variations in the Acute Response to Exercise in Chronic Obstructive Pulmonary Disease
Chan-Thim, E. (2011) · Asian Test Symposium · doi:10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4591
Lung Transplantation for Chronic Obstructive Pulmonary Disease
Sager, J. S., & Kotloff, R. M. (2007) · Clinical Pulmonary Medicine · doi:10.1097/01.cpm.0000263563.50664.57
Chronic Obstructive Pulmonary Disease (COPD): A Review of the Clinical Management
Umoh, V. A. (2015) · The Nigerian Health Journal · doi:10.60787/tnhj.v13i1.149
Newton, M. F., O'Donnell, D., & Forkert, L. (2002) · Revista Portuguesa de Pneumologia · doi:10.1016/s0873-2159(15)30779-0
Bronchodilator therapy in COPD: physiological effects
O’Donnell, D. E. (2008) · Breathe · doi:10.1183/18106838/breathe.4.4.342
Rodrigues, J. C. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2009.tde-31032009-092502
Management of acute exacerbations of chronic pulmonary obstructive disease
Cervantes, O. G. (2009)
Ofir, D. (2008) · QSpace (Queen's University Library)
Scuarcialupi, M. E. C. D. A., Berton, D. C., Cordoni, P. K., Squassoni, S. D., Fiss, E., & Neder, J. A. (2014)
high-intensity, constant-work-rate exercise in COPD Sensory-mechanical relationships during
Hamilton, A. L., & Webb, K. A. (2006)
Macklem, T., Pedotti, A., Duranti, R., Scano, G., Śliwiński, P., Yan, S., Aliverti, A., Kayser, B., Cala, S. J., Taylor, B. J., et al. (2015)
Monteiro, M. B. (2008) · Americanae (AECID Library)
Outcome Measures and Prognostic Markers for COPD
Cazzola, M., & Make, B. J. (2010) · Humana Press eBooks · doi:10.1007/978-1-59745-357-8_4
Emphysème pulmonaire Grands syndromes anatomocliniques
de Crémoux, H., Bignon, J., & Defouilloy, C. (2004) · Encyclopédie médico-chirurgicale. Pneumologie · doi:10.1016/s1155-195x(03)00076-8
Deshpande, A., & Caira, J. (2003) · Primary Care Respiratory Journal · doi:10.1038/pcrj.2003.19
Chapter 19 Pathophysiology of Chronic Obstructive Pulmonary Disease
Celli, B. R. (2002)
COPDhyperoxia on exertional dyspnoea in normoxic Combined physiological effects of bronchodilators
Peters, M., & Webb, K. A. (2006)
Ichinose, M. (2015) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.104.1108
[Pharmacological therapy of chronic obstructive pulmonary disease].
Montuschi, P. (2003) · PubMed
Ichinose, M. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.1822
Use of Expiratory Airflows and Lung Volumes to Assess Outcomes in COPD
Ferguson, G. T. (2003) · Lung biology in health and disease · doi:10.1201/9780203913406.pt2
Sciurba, F. C., & Salzman, S. H. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06861-4.50006-x
ß-Adrenergic Receptor Agonist Bronchodilators in the Treatment of COPD
Rennard, S. (2003) · Lung biology in health and disease · doi:10.1201/9780203913406.ch13
Farré, R., Scano, G., Stendardi, L., & Grazzini, M. (2016)
Soares, A. L. P., Pereira, C., & Rodrigues, S. C. S. (2013) · DOAJ (DOAJ: Directory of Open Access Journals)
Domiciliary ambulatory oxygen in chronic obstructive pulmonary disease
Moore, R. P. (2010) · Minerva Access (University of Melbourne)
Wie sollen Kortikosteroide bei der COPD angewandt werden?
Redaktion, D. (2001) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2001.04095
Johnson, M. W. (2007) · doi:10.1002/9780470755976.ch57
The Control of Airway Function and the Assessment of Airway Calibre
Derom, E., & Joos, G. (2020) · doi:10.1002/9781118597309.ch15
Bagdonas, A. (2009) · Pulmonology and allergology · doi:10.37499/pia.480
Викторович, Л. И., & Esaulova, N. A. (2005) · PULMONOLOGIYA · doi:10.18093/0869-0189-2005-0-3-108-118
Fluimucil and recent clinical practice
Chikina, S. Y. (2005) · PULMONOLOGIYA · doi:10.18093/0869-0189-2005-0-4-97-111
Frequency of obstructive pattern on spirometry in asymptomatic chronic smokers.
Umer, Z., Hayat, I., Waseem, M., Aziz, N., Afzal, H. S., & Kamal, Z. (2020) · The Professional Medical Journal · doi:10.29309/tpmj/2020.27.10.5432
Clinical Consequences of the Airflow Limitation
Tantucci, C., Ferretti, A., & Grassi, V. (2000) · Springer eBooks · doi:10.1007/978-88-470-2286-7_16
Terzano, C., & D’Antoni, L. (2008) · Springer eBooks · doi:10.1007/978-88-470-0467-2_13
Webb, K. A., & O’Donnell, D. E. (2003) · Lung biology in health and disease · doi:10.1201/9780203913406.ch3
The utility of cardiopulmonary exercise testing in evaluating the efficacy of treatment in COPD
Corriveau, S. (2015) · Shortness of Breath · doi:10.11138/sob/2015.4.3.088
Bronchopneumopathie chronique obstructive et activité physique
Coste, O. (2016) · Elsevier eBooks · doi:10.1016/b978-2-294-74464-8.00011-5
&NA; (1971) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197112000-00009
Kitamura, S., Tsuchiya‐Ito, R., Taguchi, R., Ishikawa, T., Ota, T., & Hamada, S. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06303-y
Ozdemir, I. (2025) · Springer eBooks · doi:10.1007/978-3-032-06268-0_73
Physiologic Assessment of COPD
Travers, J., Laveneziana, P., & O’Donnell, D. E. (2010) · Humana Press eBooks · doi:10.1007/978-1-59745-357-8_3
Metadata
- Authors
- Belman, M. J., Botnick, W. C., & Shin, J. W.
- Affiliations
- Cedars-Sinai Medical Center (US)
- ORCID
- Shin, J W
- Venue
- American journal of respiratory and critical care medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-03-01
- Volume
- 153
- Issue
- 3
- Pages
- 967-975
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2007810665
- Cited by
- 402
- References
- 21
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 1 · 2021: 1 · 2020: 8 · 2019: 5 · 2018: 1 · 2017: 4 · 2016: 9 · 2015: 6 · 2014: 8 · 2013: 10 · 2012: 10
- FWCI
- 11.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- dynamic hyperinflation, chronic obstructive pulmonary disease, inhaled beta-agonists, salbutamol, esophageal pressure, end-expiratory lung volume, inspiratory capacity, pressure-volume loops, inspiratory muscle strength, inspiratory muscle endurance, inspiratory muscle training
- MeSH terms
- Administration, Inhalation, Adrenergic beta-Agonists, Aged, Albuterol, Bronchodilator Agents, Dyspnea, Esophagus, Physical Exertion, Female, Forced Expiratory Volume, Humans, Inspiratory Capacity, Lung, Lung Diseases, Obstructive, Male, Middle Aged, Peak Expiratory Flow Rate, Pressure, Pulmonary Ventilation, Total Lung Capacity, Vital Capacity, Respiratory Mechanics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review